The routine examination of cervical cells, commonly performed during a pelvic exam, is primarily designed to detect precancerous and cancerous changes in the cervix. This screening procedure involves collecting cells from the cervix and examining them under a microscope. The primary goal is to identify cellular abnormalities that could indicate the presence of cervical dysplasia, a precursor to cervical cancer, or cervical cancer itself.
Early detection of cervical abnormalities through this screening process is crucial because it allows for timely intervention and treatment, significantly reducing the risk of developing invasive cervical cancer. The widespread adoption of this screening method has dramatically decreased the incidence and mortality rates associated with cervical cancer globally. Its significance lies in its ability to identify cellular changes years before cancer develops, affording healthcare providers ample opportunity to implement preventative measures.
